WHO 药品预认证与检查动态·· 2026-07-10AI 评分52
WHO 将意大利 Chiesi 的咖啡因柠檬酸盐输注液及口服液列入预认证清单
Chiesi Caffeine citrate solution for infusion and oral solution prequalified
AI 导读
WHO 预认证部门于 2026 年 7 月 10 日将意大利 Chiesi Farmaceutici S.p.A. 的咖啡因柠檬酸盐输注液及口服液（60 mg/3 mL，编号 AP003）列入预认证清单。该产品用于治疗早产儿呼吸暂停。
正文
News
10 July, 2026 - 00:12 (CEST)
Announcement
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
• AP003 Caffeine citrate Solution for Infusion and oral solution 60 mg/3 mL – Chiesi Farmaceutici S.p.A. – Italy
Caffeine citrate products are used in the treatment of Apnoea in Preterm infants.
来源：WHO 药品预认证与检查动态 · extranet.who.int